Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Diagnostic Nuclear Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diagnostic Nuclear Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diagnostic Nuclear Medicines Overall Market Size
2.1 Global Diagnostic Nuclear Medicines Market Size: 2021 VS 2028
2.2 Global Diagnostic Nuclear Medicines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diagnostic Nuclear Medicines Sales: 2017-2028
3 Company Landscape
3.1 Top Diagnostic Nuclear Medicines Players in Global Market
3.2 Top Global Diagnostic Nuclear Medicines Companies Ranked by Revenue
3.3 Global Diagnostic Nuclear Medicines Revenue by Companies
3.4 Global Diagnostic Nuclear Medicines Sales by Companies
3.5 Global Diagnostic Nuclear Medicines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diagnostic Nuclear Medicines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diagnostic Nuclear Medicines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diagnostic Nuclear Medicines Players in Global Market
3.8.1 List of Global Tier 1 Diagnostic Nuclear Medicines Companies
3.8.2 List of Global Tier 2 and Tier 3 Diagnostic Nuclear Medicines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Diagnostic Nuclear Medicines Market Size Markets, 2021 & 2028
4.1.2 Tc-99m
4.1.3 F-18
4.1.4 Other
4.2 By Type - Global Diagnostic Nuclear Medicines Revenue & Forecasts
4.2.1 By Type - Global Diagnostic Nuclear Medicines Revenue, 2017-2022
4.2.2 By Type - Global Diagnostic Nuclear Medicines Revenue, 2023-2028
4.2.3 By Type - Global Diagnostic Nuclear Medicines Revenue Market Share, 2017-2028
4.3 By Type - Global Diagnostic Nuclear Medicines Sales & Forecasts
4.3.1 By Type - Global Diagnostic Nuclear Medicines Sales, 2017-2022
4.3.2 By Type - Global Diagnostic Nuclear Medicines Sales, 2023-2028
4.3.3 By Type - Global Diagnostic Nuclear Medicines Sales Market Share, 2017-2028
4.4 By Type - Global Diagnostic Nuclear Medicines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Diagnostic Nuclear Medicines Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - Global Diagnostic Nuclear Medicines Revenue & Forecasts
5.2.1 By Application - Global Diagnostic Nuclear Medicines Revenue, 2017-2022
5.2.2 By Application - Global Diagnostic Nuclear Medicines Revenue, 2023-2028
5.2.3 By Application - Global Diagnostic Nuclear Medicines Revenue Market Share, 2017-2028
5.3 By Application - Global Diagnostic Nuclear Medicines Sales & Forecasts
5.3.1 By Application - Global Diagnostic Nuclear Medicines Sales, 2017-2022
5.3.2 By Application - Global Diagnostic Nuclear Medicines Sales, 2023-2028
5.3.3 By Application - Global Diagnostic Nuclear Medicines Sales Market Share, 2017-2028
5.4 By Application - Global Diagnostic Nuclear Medicines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Diagnostic Nuclear Medicines Market Size, 2021 & 2028
6.2 By Region - Global Diagnostic Nuclear Medicines Revenue & Forecasts
6.2.1 By Region - Global Diagnostic Nuclear Medicines Revenue, 2017-2022
6.2.2 By Region - Global Diagnostic Nuclear Medicines Revenue, 2023-2028
6.2.3 By Region - Global Diagnostic Nuclear Medicines Revenue Market Share, 2017-2028
6.3 By Region - Global Diagnostic Nuclear Medicines Sales & Forecasts
6.3.1 By Region - Global Diagnostic Nuclear Medicines Sales, 2017-2022
6.3.2 By Region - Global Diagnostic Nuclear Medicines Sales, 2023-2028
6.3.3 By Region - Global Diagnostic Nuclear Medicines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diagnostic Nuclear Medicines Revenue, 2017-2028
6.4.2 By Country - North America Diagnostic Nuclear Medicines Sales, 2017-2028
6.4.3 US Diagnostic Nuclear Medicines Market Size, 2017-2028
6.4.4 Canada Diagnostic Nuclear Medicines Market Size, 2017-2028
6.4.5 Mexico Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diagnostic Nuclear Medicines Revenue, 2017-2028
6.5.2 By Country - Europe Diagnostic Nuclear Medicines Sales, 2017-2028
6.5.3 Germany Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5.4 France Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5.5 U.K. Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5.6 Italy Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5.7 Russia Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5.8 Nordic Countries Diagnostic Nuclear Medicines Market Size, 2017-2028
6.5.9 Benelux Diagnostic Nuclear Medicines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diagnostic Nuclear Medicines Revenue, 2017-2028
6.6.2 By Region - Asia Diagnostic Nuclear Medicines Sales, 2017-2028
6.6.3 China Diagnostic Nuclear Medicines Market Size, 2017-2028
6.6.4 Japan Diagnostic Nuclear Medicines Market Size, 2017-2028
6.6.5 South Korea Diagnostic Nuclear Medicines Market Size, 2017-2028
6.6.6 Southeast Asia Diagnostic Nuclear Medicines Market Size, 2017-2028
6.6.7 India Diagnostic Nuclear Medicines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diagnostic Nuclear Medicines Revenue, 2017-2028
6.7.2 By Country - South America Diagnostic Nuclear Medicines Sales, 2017-2028
6.7.3 Brazil Diagnostic Nuclear Medicines Market Size, 2017-2028
6.7.4 Argentina Diagnostic Nuclear Medicines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diagnostic Nuclear Medicines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diagnostic Nuclear Medicines Sales, 2017-2028
6.8.3 Turkey Diagnostic Nuclear Medicines Market Size, 2017-2028
6.8.4 Israel Diagnostic Nuclear Medicines Market Size, 2017-2028
6.8.5 Saudi Arabia Diagnostic Nuclear Medicines Market Size, 2017-2028
6.8.6 UAE Diagnostic Nuclear Medicines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Corporate Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Diagnostic Nuclear Medicines Major Product Offerings
7.1.4 Bracco Imaging Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.1.5 Bracco Imaging Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Diagnostic Nuclear Medicines Major Product Offerings
7.2.4 Bayer Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Key News
7.3 Curium Pharmaceuticals
7.3.1 Curium Pharmaceuticals Corporate Summary
7.3.2 Curium Pharmaceuticals Business Overview
7.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Major Product Offerings
7.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.3.5 Curium Pharmaceuticals Key News
7.4 Nordion
7.4.1 Nordion Corporate Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Diagnostic Nuclear Medicines Major Product Offerings
7.4.4 Nordion Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.4.5 Nordion Key News
7.5 Triad Isotopes
7.5.1 Triad Isotopes Corporate Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Diagnostic Nuclear Medicines Major Product Offerings
7.5.4 Triad Isotopes Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.5.5 Triad Isotopes Key News
7.6 Lantheus
7.6.1 Lantheus Corporate Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Diagnostic Nuclear Medicines Major Product Offerings
7.6.4 Lantheus Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.6.5 Lantheus Key News
7.7 GE Healthcare
7.7.1 GE Healthcare Corporate Summary
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Diagnostic Nuclear Medicines Major Product Offerings
7.7.4 GE Healthcare Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.7.5 GE Healthcare Key News
7.8 China Isotope & Radiation
7.8.1 China Isotope & Radiation Corporate Summary
7.8.2 China Isotope & Radiation Business Overview
7.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Major Product Offerings
7.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.8.5 China Isotope & Radiation Key News
7.9 Jubilant Pharma
7.9.1 Jubilant Pharma Corporate Summary
7.9.2 Jubilant Pharma Business Overview
7.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Major Product Offerings
7.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.9.5 Jubilant Pharma Key News
7.10 Eli Lilly
7.10.1 Eli Lilly Corporate Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Diagnostic Nuclear Medicines Major Product Offerings
7.10.4 Eli Lilly Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.10.5 Eli Lilly Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Diagnostic Nuclear Medicines Business Overview
7.11.3 Novartis Diagnostic Nuclear Medicines Major Product Offerings
7.11.4 Novartis Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.11.5 Novartis Key News
7.12 SIEMENS
7.12.1 SIEMENS Corporate Summary
7.12.2 SIEMENS Diagnostic Nuclear Medicines Business Overview
7.12.3 SIEMENS Diagnostic Nuclear Medicines Major Product Offerings
7.12.4 SIEMENS Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.12.5 SIEMENS Key News
7.13 Dongcheng
7.13.1 Dongcheng Corporate Summary
7.13.2 Dongcheng Diagnostic Nuclear Medicines Business Overview
7.13.3 Dongcheng Diagnostic Nuclear Medicines Major Product Offerings
7.13.4 Dongcheng Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.13.5 Dongcheng Key News
7.14 Navidea
7.14.1 Navidea Corporate Summary
7.14.2 Navidea Business Overview
7.14.3 Navidea Diagnostic Nuclear Medicines Major Product Offerings
7.14.4 Navidea Diagnostic Nuclear Medicines Sales and Revenue in Global (2017-2022)
7.14.5 Navidea Key News
8 Global Diagnostic Nuclear Medicines Production Capacity, Analysis
8.1 Global Diagnostic Nuclear Medicines Production Capacity, 2017-2028
8.2 Diagnostic Nuclear Medicines Production Capacity of Key Manufacturers in Global Market
8.3 Global Diagnostic Nuclear Medicines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Diagnostic Nuclear Medicines Supply Chain Analysis
10.1 Diagnostic Nuclear Medicines Industry Value Chain
10.2 Diagnostic Nuclear Medicines Upstream Market
10.3 Diagnostic Nuclear Medicines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diagnostic Nuclear Medicines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer